Green Cross Health reports FY25 results; PSRs vest

Green Cross Health (NZX:GXH) has reported its full-year results for the twelve months ended 31 March 2025, posting Operating Revenue of NZD 523.8m and Net Profit After Tax Attributable to Shareholders of NZD 16.0m. Amidst a challenging economic and healthcare landscape, the company has focused on cost control and evolving its operating model while investing over NZD 85m in technology and site improvements over the past five years. Dispensary performance remained strong, with same store prescriptions up 4% compared to 31 March 2024. The company has been investing in expanding and improving its pharmacy and medical center network. The Board has declared a final dividend of 2.75 cents per share. Concurrently, Green Cross Health announced the vesting of 114,094 Performance Share Rights (PSRs) under its Performance Share Rights Scheme, authorized by a board resolution on 28 May 2025. This results in a total of 143,716,692 ordinary shares outstanding, with 325,420 PSRs remaining under the scheme.